ICLR
NasdaqICON plc
Industrials · Services-Commercial Physical & Biological Research
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$5.5B
2021
$7.7B
2022
$8.1B
2023
$8.2B
2024
$8.3B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$8.3B
Net Income$229.3M
Gross Profit—
Oper Income$442.8M
EPS (dil)$2.90
Rev/sh$107.77
FCF/sh$11.26
Book/sh$120.07
Gross M—
Oper M5.4%
Profit M2.8%
FCF M10.4%
ROE2.5%
ROA1.4%
ROIC3.5%
R&D/Rev—
Rev Y/Y0.8%
Rev 3Y CAGR2.1%
EPS Y/Y-67.4%
EPS 3Y CAGR-22.1%
FCF 3Y CAGR27.0%
Payout—
Div/sh—
Shs Chg Y/Y-4.9%
Current Ratio1.10
Quick Ratio1.09
Debt/Eq0.32
Int Coverage2.2×
Net Debt$2.3B
Total Debt$2.9B
Cash & Eq$647.3M
Total Assets$16.3B
Oper CF$1.0B
Capex$174.2M
Free CF$862.0M
Buybacks$750.0M
Equity$9.2B
Liabilities$7.1B
Shs Outstand0.08B
SectorIndustrials
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5.5B | $7.7B | $8.1B | $8.2B | $8.3B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $378.5M | $795.2M | $904.7M | $1.0B | $442.8M |
| Net Income | $153.2M | $505.3M | $554.2M | $739.1M | $229.3M |
| Diluted EPS | $2.25 | $6.13 | $6.70 | $8.90 | $2.90 |
| Operating Cash Flow | $829.1M | $563.3M | $1.2B | $1.3B | $1.0B |
| Free Cash Flow | $735.4M | $421.2M | $1.0B | $1.1B | $862.0M |
COMMUNITY · $ICLR0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.